Whole-Inactivated and Virus-Like Particle Vaccine Strategies for Chikungunya Virus.

ABSTRACT: Chikungunya virus (CHIKV) is a global public health threat, having been identified in >60 countries in Asia, Africa, Europe, and the Americas. There is no cure for or licensed vaccine against CHIKV infection. Initial attempts at CHIKV vaccine development began in the early 1960s. Whole-inactivated and virus-like particle (VLP) vaccines are 2 of the current approaches being evaluated. Success of these approaches is dependent on a safe, well-tolerated vaccine that is immunogenic and deployable in regard to manufacturing, stability, and delivery characteristics.

SUBMITTER: DeZure AD 

PROVIDER: S-EPMC5137244 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature